| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Giovanni Fazio, Daniele Olivo, Nadine D Wolf, Dusan Hirjak, Mike M Schmitgen, Florian Werler, Miriam Witteman, Katharina M Kubera, Vince D Calhoun, Wolfgang Reith, Robert Christian Wolf, Fabio Sambatar. The risk of cannabis use disorder is mediated by altered brain connectivity: A chronnectome study. Addiction biology. vol 29. issue 5. 2024-05-06. PMID:38709211. |
the brain mechanisms underlying the risk of cannabis use disorder (cud) are poorly understood. |
2024-05-06 |
2024-05-08 |
Not clear |
| Rachel Lees, Will Lawn, Kat Petrilli, Amelia Brown, Katie Trinci, Anya Borissova, Shelan Ofori, Claire Mokrysz, H Valerie Curran, Lindsey A Hines, Tom P Freema. Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study. European archives of psychiatry and clinical neuroscience. 2024-05-06. PMID:38709252. |
adolescence is a developmental period characterised by increased vulnerability to cannabis use disorder (cud). |
2024-05-06 |
2024-05-08 |
human |
| Rachel Lees, Will Lawn, Kat Petrilli, Amelia Brown, Katie Trinci, Anya Borissova, Shelan Ofori, Claire Mokrysz, H Valerie Curran, Lindsey A Hines, Tom P Freema. Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study. European archives of psychiatry and clinical neuroscience. 2024-05-06. PMID:38709252. |
here, we aimed to investigate the one-year course of cud in adolescents compared to adults who currently use cannabis, adjusting for a comprehensive measure of cannabis quantity. |
2024-05-06 |
2024-05-08 |
human |
| Rachel Lees, Will Lawn, Kat Petrilli, Amelia Brown, Katie Trinci, Anya Borissova, Shelan Ofori, Claire Mokrysz, H Valerie Curran, Lindsey A Hines, Tom P Freema. Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study. European archives of psychiatry and clinical neuroscience. 2024-05-06. PMID:38709252. |
the primary outcome was cud symptoms measured using the cannabis use disorder identification test revised (cudit-r) at five time points. |
2024-05-06 |
2024-05-08 |
human |
| John L Havlik, Taeho G Rhee, Robert A Rosenhec. Association of mental health related quality of life and other factors with treatment seeking for substance use disorders: A comparison of SUDs rooted in legal, partially legal, and illegal substances. PloS one. vol 19. issue 4. 2024-04-29. PMID:38683850. |
our analysis used nationally-representative data from the nesarc-iii database of those experiencing past-year suds (n = 5,808) to compare rates of treatment use and its correlates among three groups: those with illicit substance use disorders (isuds); those with partially legal substance use disorders, i.e., cannabis use disorder (cud); and those with fully legal substance use disorders, i.e., alcohol use disorder (aud). |
2024-04-29 |
2024-05-03 |
Not clear |
| Nora D Volkow, Wilson M Compton, Carlos Blanco, Emily B Einstein, Beth Ha. Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior among young adults in the United States. The International journal on drug policy. vol 128. 2024-04-27. PMID:38677161. |
most violent crimes (52 %) are committed by adults aged 18-34, who account for 23 % of the us population and have the highest prevalence of cannabis use and cannabis use disorder (cud). |
2024-04-27 |
2024-04-30 |
Not clear |
| Nora D Volkow, Wilson M Compton, Carlos Blanco, Emily B Einstein, Beth Ha. Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior among young adults in the United States. The International journal on drug policy. vol 128. 2024-04-27. PMID:38677161. |
we examined whether and how associations of cannabis use, use frequency, and cud with violent behavior (i.e., attacking someone with the intent to harm seriously) vary by sex in u.s. young adults. |
2024-04-27 |
2024-04-30 |
Not clear |
| Rose Chesworth, Howard Chi-Ho Yim, Georgia Watt, Emad El-Omar, Tim Kar. Cannabidiol (CBD) facilitates cocaine extinction and ameliorates cocaine-induced changes to the gut microbiome in male C57BL/6JArc mice. Progress in neuro-psychopharmacology & biological psychiatry. 2024-04-22. PMID:38649130. |
a novel therapeutic candidate for cud, cannabidiol (cbd), can improve gut function in rodent models. |
2024-04-22 |
2024-04-26 |
mouse |
| Richard J Macatee, Mallory J Cannon, Brandon S Schermitzler, Thomas J Preston, Kaveh Afsha. Biological sex and hormonal contraceptive associations with drug cue reactivity in cannabis use disorder. Journal of psychiatric research. vol 174. 2024-04-16. PMID:38626562. |
biological sex differences in cannabis use disorder (cud) progression, cannabis withdrawal severity, and pharmacotherapy response have been reported, suggesting that cud mechanisms may differ by sex. |
2024-04-16 |
2024-04-19 |
Not clear |
| Richard J Macatee, Mallory J Cannon, Brandon S Schermitzler, Thomas J Preston, Kaveh Afsha. Biological sex and hormonal contraceptive associations with drug cue reactivity in cannabis use disorder. Journal of psychiatric research. vol 174. 2024-04-16. PMID:38626562. |
the aim of the present study was to test whether sex differences in neural cannabis cue reactivity and craving varied by female hc use in a cud sample. |
2024-04-16 |
2024-04-19 |
Not clear |
| Muhammad M Munir, Selamawit Woldesenbet, Yutaka Endo, Mary Dillhoff, Timothy M Pawli. Cannabis use disorder and perioperative outcomes following complex cancer surgery. Journal of surgical oncology. 2024-04-12. PMID:38606521. |
we sought to evaluate whether cannabis use disorder (cud) was associated with higher morbidity and mortality among patients undergoing complex cancer surgery. |
2024-04-12 |
2024-04-14 |
Not clear |
| Lidia Emmanuela Wiazowski Spelta, Caroline Cristiano Real, Vitor Bruno, Carlos Alberto Buchpiguel, Raphael Caio Tamborelli Garcia, Larissa Helena Torres, Daniele de Paula Faria, Tania Marcouraki. Impact of cannabidiol on brain glucose metabolism of C57Bl/6 male mice previously exposed to cocaine. Journal of neuroscience research. vol 102. issue 4. 2024-04-08. PMID:38588037. |
despite evidence of the beneficial effects of cannabidiol (cbd) in animal models of cocaine use disorder (cud), cbd neuronal mechanisms remain poorly understood. |
2024-04-08 |
2024-04-11 |
mouse |
| Carsten Hjorthøj, Anne Stürup, Mette Karlsen, Helene Speyer, Merete Osler, Dost Ongur, Merete Nordentof. Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study. Psychological medicine. 2024-04-04. PMID:38571303. |
we aimed to investigate whether use of antipsychotic medication, benzodiazepines, and psychiatric service use differs among patients with schizophrenia depending on whether psychosis was precipitated by a diagnosis of cannabis use disorder (cud). |
2024-04-04 |
2024-04-06 |
Not clear |
| Mohammad Ghafouri, Sabrina Correa da Costa, Ali Zare Dehnavi, Mark S Gold, Teresa A Rumman. Treatments for Cannabis Use Disorder across the Lifespan: A Systematic Review. Brain sciences. vol 14. issue 3. 2024-03-28. PMID:38539616. |
cannabis use disorder (cud) is a growing public health concern, with rising prevalence and significant impact on individuals across age groups. |
2024-03-28 |
2024-03-30 |
Not clear |
| Mohammad Ghafouri, Sabrina Correa da Costa, Ali Zare Dehnavi, Mark S Gold, Teresa A Rumman. Treatments for Cannabis Use Disorder across the Lifespan: A Systematic Review. Brain sciences. vol 14. issue 3. 2024-03-28. PMID:38539616. |
database searches were conducted for randomized controlled trials of cud interventions reporting outcomes such as cannabis use, abstinence, withdrawal symptoms, and treatment retention. |
2024-03-28 |
2024-03-30 |
Not clear |
| b' Alexander Denissoff, Heidi Taipale, Jari Tiihonen, Marta Di Forti, Ellenor Mittendorfer-Rutz, Antti Tanskanen, Antti Mustonen, Solja Niemel\\xc3\\xa. Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study. Schizophrenia bulletin. 2024-03-27. PMID:38534050.' |
there is a paucity of research on treatment outcomes of patients with psychosis and cannabis use disorder (cud). |
2024-03-27 |
2024-03-29 |
Not clear |
| Ardavan Mohammad Aghaei, Lia Urban Spillane, Brian Pittman, L Taylor Flynn, Joao P De Aquino, Anahita Bassir Nia, Mohini Ranganatha. Sex Differences in the Acute Effects of Oral THC: A Randomized, Placebo-Controlled, Crossover Human Laboratory Study. medRxiv : the preprint server for health sciences. 2024-03-19. PMID:38077095. |
recent reports have shown increased cannabis use among women, leading to growing concerns about cannabis use disorder (cud). |
2024-03-19 |
2024-03-21 |
human |
| Daniel Feingold, Dana Tzur Bitan, Marica Ferri, Eva Hoc. Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature. European archives of psychiatry and clinical neuroscience. 2024-03-17. PMID:38493284. |
treatment demand for cannabis use disorder (cud) has increased in the past decade in almost all european countries, and cud is currently the most common reason for first-time drug-related treatment admission in the european union. |
2024-03-17 |
2024-03-19 |
Not clear |
| Brittany Bass, Howard Padwa, Dhruv Khurana, Darren Urada, Anne Boustea. Adult use cannabis legalization and cannabis use disorder treatment in California, 2010-2021. Journal of substance use and addiction treatment. 2024-03-17. PMID:38494048. |
this paper contributes to knowledge of adult use legalization's associations with cannabis use disorder (cud) treatment utilization. |
2024-03-17 |
2024-03-20 |
Not clear |
| William Wang, Nora D Volkow, Nathan A Berger, Pamela B Davis, David C Kaelber, Rong X. Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study. Molecular psychiatry. 2024-03-15. PMID:38486046. |
cannabis is the most frequently used illicit drug in the united states with more than 45 million users of whom one-third suffer from a cannabis use disorder (cud). |
2024-03-15 |
2024-03-17 |
Not clear |